Table 3.
Treatment Outcomes | Initial Assessment | Final (Week 8) Assessment | z Value * | p Value | |||
---|---|---|---|---|---|---|---|
Mean | (SD) | % (N) | Mean | (SD) | |||
Response rate | 40 (6) | ||||||
Remission rate | 27 (4) | ||||||
CGI-S | 3.80 | (0.68) | 3.07 | (0.88) | z = −2.50 | 0.019 ** | |
CGI-I (lower scores reflect more improvement) | 2.67 | (1.05) | z = −2.98 | 0.003 ** | |||
HAM-D17 | 17.73 | (2.55) | 11.87 | (4.75) | z = −3.07 | 0.002 ** | |
BDI | 27.53 | (8.94) | 19.97 | (13.10) | z = −2.47 | 0.013 ** | |
Q-LES-Q | 0.38 | (0.12) | 0.47 | (0.13) | z = −3.12 | 0.002 ** | |
MSPSS-SO | 12.93 | (7.50) | 16.40 | (7.42) | z = −1.81 | 0.071 | |
MSPSS-FA | 13.93 | (7.21) | 15.60 | (8.08) | z = −2.78 | 0.006 ** | |
MSPSS-FR | 12.93 | (7.06) | 16.67 | (7.93) | z = −1.69 | 0.093 |
Notes: *Wilcoxon Signed Rank test. The W values are available upon request. ** Statistically significant (p < 0.05).